Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemic knock-out mice expressing truncated apoB, B81. Low production and enhanced clearance of apoB cause low levels of apoB

Molecular and Cellular Biochemistry

Volumn 202, Issue 1-2, 1999, Pages 37-46

  Srivastava, Rai Ajit K ^a   Toth, Lori ^a   Srivastava, Neelam ^b   Hinsdale, Myron E ^c   Maeda, Nobuyo ^d   Cefalu', Angelo B ^d   Averna, Maurizio ^b   Schonfeld, Gustav ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PALERMO   (Italy)

^d MONSANTO COMPANY   (United States)

Author keywords

ApoB48; Apolipoprotein B; Clearance; MRNA metabolism; Nonsense mutation; Secretion; Synthesis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; FEMALE; GENE MUTATION; HETEROZYGOTE; HYPOBETALIPOPROTEINEMIA; KNOCKOUT MOUSE; LIPOPROTEIN BLOOD LEVEL; LIVER CELL; MOUSE; NONHUMAN; NONSENSE MUTATION; RNA METABOLISM; RNA TRANSCRIPTION; STOP CODON;

EID: 0033378987     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007030531478     Document Type: Article

References (47)

1. Kane JP: Apolipoprotein B: Structural and metabolic heterogeneity. Ann Rev Biochem 45: 637-650, 1983
2. Lau PP, Xiong WJ, Zhu HJ, Chen SH, Chan L: Apolipoprotein B mRNA editing is an intracellular event that occurs posttranscriptionally coincident with splicing and polyadenylation. J Biol Chem 266: 20550-20554, 1991
3. Greeve J, Altkemper I, Dieterich JH, Greten H, Windler E: Apolipoprotein B mRNA editing in 12 different mammalian species: Hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res 34: 1367-1383, 1993
4. Srivastava RAK, Tang J, Baumann D, Schonfield G: Hormonal and nutritional stimuli modulate apolipoprotein B mRNA editing in mouse liver. Biochem Biophys Res Commun 188: 135-141, 1992
5. Yang C-Y, Chen S-H, Gianturco SH, Bradley WA, Sparrow JT, Tanimura M, Lee F-S, Gu Z-W, Gotto AM, Chan L: Sequence, structure, receptor binding domains and internal repeats of human apolipoprotein B-100. Nature (London) 323: 738-742, 1986
6. Linton MF, Farese RV Jr., Young SG: Familial Hypobetalipoproteinemia. J Lipid Res 34: 521-541, 1993
7. Groenewegen WA, Krul ES, Averna MA, Pulai J, Schonfeld G: Dysbetalipoproteinemia in a kindred with hypobetalipoproteinemia due to mutations in the genes for apoB (apoB-70.5) and apoE (apoE2). Arterioscler Thromb 14: 1695-1704, 1994
8. Srivastava N, Noto D, Averna M, Pulai J, Srivastava RAK, Cole TG, Latour MA, Patterson BW, Schonfeld G: A new apolipoprotein B truncation (apo B-43.7) in familial hypobetalipoproteinemia: Genetic and metabolic studies. Metab Clin Exp 45: 1296-1304, 1996
9. Parhofer KG, Barrett PHR, Bier DM, Schonfeld G: Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate (in vivo studies in apoB-89, apoB-75, apoB-54.8 and apoB-31 heterozygotes). J Lipid Res 37: 844-852, 1996
10. Aguilar-Salinas CA, Barrett PHR, Parhofer KG, Young D, Tessereau D, Bateman J, Quinn C, Schonfeld G: Apolipoprotein B100 production is decreased in subjects heterozygous for truncations of apolipoprotein B. Arterioscler Thromb 15: 71-80, 1995
11. Smithies O, Maeda N: Gene targeting approaches to complex genetic diseases: Atherosclerosis and essential hypertension. Proc Natl Acad Sci USA 92: 5266-5272, 1995
12. Homanics GE, Smith TJ, Zhang SH, Lee D, Young SG, Maeda N: Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc Natl Acad Sci USA 90: 2389-2393, 1993
13. Toth L, Smith TJ, Jones C, deSilva HV, Smithies O, Maeda N: Two distinct apolipoprotein B alleles in mice generated by a single 'in-out' targeting. Gene 178: 161-168, 1996
14. Farese RV, Ruland SL, Flynn LM, Stokowski RP, Young SG: Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc Natl Acad Sci USA 92: 1774-1778, 1995
15. Kim E, Cham CM, Veniant MM, Ambroziak P, Young SG: Dual mechanisms for the low plasma levels of truncated apolipoprotein B proteins in familial hypobetalipoproteinemia. Analysis of a new mouse model with a nonsense mutation in the apoB gene. J Clin Invest 101:1468-1477, 1998
16. Pullinger CR, North JD, Teng B-B, Rifici VA, Ronhild de Brito, Scott J: The apolipoprotein B gene is constitutively expressed in HepG2 cells: Regulation of secretion by oleic acid, albumin, insulin and measurement of the mRNA half-life. J Lipid Res 30: 1065-1077, 1989
17. Moberly JB, Cole TG, Alpers DH, Schonfeld G: Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco2 cells occurs posttranscriptionally. Biochim Biophys Acta 1042: 70-80, 1990
18. Dixon JL, Furukawa S, Ginsberg HN: Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from HepG2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem 266: 5080-5086, 1991
19. Davis RA, Thrift RN, Wu CC, Howell KE: Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. Evidence for two functionally distinct pools. J Biol Chem 265: 10005-10011, 1990
20. Selby SL, Yao Z: Levels of apolipoprotein B mRNA has an important effect on the synthesis and secretion of apolipoprotein B-containing lipoproteins. Studies on the transfected hepatoma cell lines expressing recombinant human apolipoprotein B. Arterioscler Throm Vas Biol 15: 1900-1910, 1995
21. Urlaub G, Mitchell PJ, Ciuda CJ, Chasin LA: Nonsense mutation in the dihydrofolate reductase gene affect RNA processing. Mol Cell Biol 9: 2868-2880, 1989
22. Mashima Y, Murakami A, Weleber RG, Kennaway NG, Clarke L, Shiono T, Inana G: Nonsense codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. Am J Hum Genet 51: 81-91, 1992
23. Frangi D, Cicardi M, Sica A, Colotta F, Agostoni A, Davus AE: Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema. J Clin Invest 88: 755-759, 1991
24. Longo N, Langley SD, Griffin LD, Elsas LJ II: Reduced mRNA and a nonsense mutation in the insulin receptor gene produce heritable severe insulin resistance. Am J Hum Genet 50: 998-1007, 1992
25. Lehrman MA, Schneider WJ, Brown MS, Davis C, Elhammer A, Russell DW, Goldstein JL: The Labanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum. J Biol Chem 262: 401-410, 1987
26. Liebhaber SA, Coleman MB, Adams JG, Cash FE, Steinberg MH: Molecular basis for nondeletion alpha-thalassemia in American blacks. Alpha 2〈116GAG......UAG〉. J Clin Invest 80: 154-159, 1987
27. Srivastava RAK, Jiao S, Tang J, Pfleger BA, Kitchens RT, Schonfeld G: In vivo regulation of LDL receptor and apoB gene expressions in inbred strains of mice by dietary fatty acids and cholesterol. Biochim. Biophys. Acta 1086: 29-43, 1991
28. Srivastava RAK, Tang J, Krul ES, Pfleger BA, Kitchens RT, Schonfeld G: Dietary fatty acids and cholesterol differ in their effects on the in vivo regulation of apoAI and AII gene expressions. Biochim Biophys Acta 1125: 251-261, 1992
29. Srivastava RAK, Srivastava N, Schonfeld G: Expression of low density lipoprotein receptor, apolipoprotein AI, AII, and AIV in various rat organs utilizing an efficient and rapid method for RNA isolation. Biochem Intern 27: 85-95, 1992
30. Srivastava RAK, Baumann D, Schonfeld G: In vivo regulation of low density lipoprotein receptor by estrogen differs at the posttranscriptional levels in rat and mouse. Eur J Biochem 216: 527-538, 1993
31. Srivastava RAK, Schonfeld G: Use of riboprobes for Northern blotting analysis. Bio/Tech 11: 584-587, 1991
32. Srivastava RAK, Pfleger BA, Schonfeld G: Expression of LDL receptor, apolipoprotein B, AI, and AIV genes in various organs of mouse by a novel solution hybridization assay. Biochim Biophys Acta 1090: 95-101, 1991
33. Srivastava RAK: Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA. Biochem Biophys Res Commun 212: 381-387, 1995
34. Williams DL, Dawson PA: Immunochemical measurements of apolipoprotein synthesis in cell and organ culture. Meth Enzymol 128: 254-271, 1986
35. Li X, Catalina F, Grundy SM, Patel S: Method to measure apolipoprotein B48 and B100 secretion rates in an individual mouse: Evidence for a very rapid turnover of VLDL and preferential removal of B48-relative to B100-containing lipoproteins. J Lipid Res 37: 210-220, 1996
36. Srivastava RAK, Srivastava N, Maurizio M, Cefalu AB, Schonfeld G: Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene. J Lipid Res 40: 901-912, 1999
37. Krul ES, Kinoshita M, Talmud P, Humphries SE, Turner S, Goldberg AC, Cook K, Boerwinkle E, Schonfeld G: Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia. Arteriosclerosis 9: 856-868, 1989
38. Farese RV Jr, Garg A, Pierotti VR, Vega GL, Young SG: A truncated species of apolipoprotein B, B83, associated with hypobetalipoproteinemia. J Lipid Res 33: 569-577, 1992
39. Krul ES, Parhofer KG, Barrett PHR, Wagner RD, Schonfeld G: ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: Genetic and kinetic studies. J Lipid Res 33: 1037-1050, 1992
40. Farese RV Jr, Veniant MM, Cham CM, Flynn LM, PierottiV, Loring JF, Traber M, Ruland S, Stokowski RS, Huszar D, Young GG: Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc Natl Acad Sci USA 93: 6393-6398, 1996
41. Parhofer KG, Daugherty A, Kinoshita M, Schonfeld G: Enhanced clearance from plasma of low density lipoproteins containing a truncated apolipoprotein, apoB -89. J Lipid Res 32: 1311-1323, 1990
42. Adeli K, Wettesten M, Asp L, Mohammadi A, Macri J, Olofsson S: Intracellular assembly and degradation of apolipoprotein B-100 containing lipoproteins in digitonin-permeabilized HepG2 cells. J Biol Chem 272: 5031-5039, 1997
43. Cartwright IJ, Habbachi A, Higgins JA: Apolipoprotein B is channeled into different compartments in hepatocytes. Biochem Soc Trans 22: 205, 1994
44. Krul ES, Tang J, Kettler TS, Clouse RE, Schonfeld G: Lengths of truncated forms of apolipoprotein B (apoB) determine their intestinal production. Biochem Biophys Res Commun 189: 1069-1076, 1992
45. Davis R, Prewett A, Thompson J, Chan P, Borchardt R, Gallaher W: Intrahepatic assembly of very low density lipoproteins: Immunologic characterization of apolipoprotein B in lipoproteins and hepatic membrane fractions and its intracellular distribution. J Lipid Res 30: 1185-1196, 1989
46. Macri J, Adeli K: Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of apoB-containing lipoprotein particles in HepG2 cells. Arterio Thromb Vasc Biol 17: 2982-2994, 1997
47. Du EZ, Kurth J, Wang S, Humiston P, Davis RA: Proteolysis-coupled secretion of the N-terminus of apolipoprotein B. Characterization of a transient, translocation arrested intermediate. J Biol Chem, 269: 24169-24176, 1994